Post-approval studies (Phase 4)Study completedNCT01465958
What this trial is testing
Pharmacokinetics, Safety, and Tolerability of Subcutaneous GAMUNEX-C in Pediatric Subjects With Primary Immunodeficiency
Who this might be right for
Primary Immunodeficiency
Grifols Therapeutics LLC 12